HealthEquity (NASDAQ:HQY) Price Target Cut to $100.00 by Analysts at Royal Bank Of Canada

HealthEquity (NASDAQ:HQY) had its price objective dropped by research analysts at Royal Bank Of Canada from $110.00 to $100.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target points to a potential upside of 22.76% from the company’s previous close.

A number of other analysts have also recently weighed in on the stock. BMO Capital Markets set a $85.00 price target on shares of HealthEquity in a research note on Tuesday, February 24th. Citizens Jmp set a $122.00 target price on shares of HealthEquity in a report on Thursday, December 4th. BTIG Research decreased their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research note on Tuesday, February 17th. Jefferies Financial Group set a $108.00 price target on HealthEquity in a report on Thursday, February 19th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research note on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $111.29.

HealthEquity Stock Performance

NASDAQ HQY traded up $2.06 on Wednesday, reaching $81.46. The stock had a trading volume of 378,499 shares, compared to its average volume of 1,019,475. The stock has a market cap of $6.96 billion, a P/E ratio of 37.40, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26. HealthEquity has a 12-month low of $72.76 and a 12-month high of $116.65. The business’s 50-day moving average price is $81.30 and its 200 day moving average price is $90.27. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. The business had revenue of $334.59 million for the quarter, compared to analyst estimates of $332.48 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. As a group, equities analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Activity

In related news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This represents a 19.33% decrease in their position. The SEC filing for this sale provides additional information. 1.50% of the stock is owned by insiders.

Hedge Funds Weigh In On HealthEquity

Large investors have recently modified their holdings of the business. Rockefeller Capital Management L.P. boosted its stake in shares of HealthEquity by 61.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 14,491 shares of the company’s stock valued at $1,328,000 after buying an additional 5,541 shares in the last quarter. Montanaro Asset Management Ltd raised its position in HealthEquity by 13.1% in the fourth quarter. Montanaro Asset Management Ltd now owns 37,200 shares of the company’s stock worth $3,408,000 after acquiring an additional 4,300 shares in the last quarter. Corient Private Wealth LLC purchased a new position in HealthEquity in the fourth quarter worth $219,000. Caitong International Asset Management Co. Ltd lifted its holdings in HealthEquity by 2,476.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 438 shares of the company’s stock valued at $40,000 after acquiring an additional 421 shares during the period. Finally, Pacer Advisors Inc. boosted its position in shares of HealthEquity by 16.9% during the 4th quarter. Pacer Advisors Inc. now owns 13,427 shares of the company’s stock worth $1,230,000 after purchasing an additional 1,937 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Key HealthEquity News

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Q4 beat and outlook raise — HealthEquity reported EPS $0.95 (vs. consensus ~$0.90) and revenue $334.6M, then raised its fiscal 2027 guidance — a direct catalyst supporting the stock today. HealthEquity beats Q4 estimates, raises FY27 guidance
• Positive Sentiment: Record revenue, profit and new HSAs — Company reported record full-year revenue ($1.31B, +9%) and net income of $215.2M (up 123%), and highlighted record new HSAs from sales, underpinning recurring fee growth. HealthEquity Reports Record Revenue, Earnings and New HSAs
• Positive Sentiment: Analyst upgrade citing better cash economics — Seeking Alpha upgraded the stock after management commentary and results suggested improved cash conversion and margin leverage, which can support a higher valuation multiple. HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)
• Positive Sentiment: Earnings call highlighted HSA growth and strong financials — Management emphasized record HSA account growth and solid operating performance in the Q4 call, supporting confidence in recurring fees and assets under administration. HealthEquity Inc (HQY) Q4 2026 Earnings Call Highlights
• Neutral Sentiment: Full transcripts and details available — Multiple transcripts and call transcripts (Seeking Alpha, Yahoo, company release) provide longer-form detail for investors wanting to audit guidance assumptions and margin drivers. HealthEquity Q4 2026 Earnings Call Transcript
• Neutral Sentiment: Analyst previews and metric deep dives — Pre- and post-earnings coverage (Zacks, Benzinga) compares key metrics to estimates and revises forecasts; useful for modeling but not immediate catalysts. Compared to Estimates, HealthEquity Q4 Earnings: A Look at Key Metrics

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.